Bio Green Med Solution, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 09/30/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $747,000 | $43,000 | $420,000 | $0 | — |
| Selling, general & administrative | — | $5.4M | $6.7M | $7.4M | — |
| Research and development | $848,000 | $6.7M | $19.2M | $20.3M | — |
| Operating expenses | $9.2M | $12.0M | $25.9M | $27.7M | — |
| Operating income | -$8.4M | -$12.0M | -$25.5M | -$27.7M | — |
| Pretax income | -$3.0M | -$12.0M | -$25.6M | -$25.9M | — |
| Income tax expense | $7,000 | -$782,000 | -$3.0M | -$4.7M | — |
| Net income | -$3.0M | -$11.2M | -$22.6M | -$21.2M | — |
| Balance Sheet | |||||
| Cash and equivalents | $3.5M | $3.1M | $3.4M | $18.3M | — |
| Current assets | $6.3M | $3.7M | $7.4M | $24.4M | — |
| Total assets | $8.2M | $4.1M | $8.8M | $28.1M | $31.6M |
| Current liabilities | $1.3M | $6.3M | $8.2M | $7.5M | $4.5M |
| Total liabilities | $1.3M | $6.3M | $8.2M | $7.6M | $4.6M |
| Stockholders' equity | $6.8M | -$2.2M | $607,000 | $15.9M | $22.5M |
| Cash Flow Statement | |||||
| Cash from operations | -$4.8M | -$8.0M | -$16.1M | -$20.8M | — |
| Depreciation and amortization | $5,000 | $6,000 | $31,000 | $32,000 | — |
| Stock-based compensation | $2.3M | $592,000 | $1.5M | $1.5M | — |
| Capital expenditure | — | — | $6,000 | $7,000 | — |
| Free cash flow | — | — | -$16.1M | -$20.8M | — |
Shares outstanding 5.5M · Free float 13.6%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.